Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.

Saved in:
Bibliographic Details
Title: Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.
Authors: Kosiborod MN; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA. Electronic address: mkosiborod@saint-lukes.org., Deanfield J; Institute of Cardiovascular Science, University College London, London, UK., Pratley R; AdventHealth Translational Research Institute, Orlando, FL, USA., Borlaug BA; Mayo Clinic, Rochester, MN, USA., Butler J; Baylor Scott & White Research Institute, Dallas, TX, USA; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA., Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, UK; National Institute for Health Research Leicester Biomedical Research Centre, Leicester, UK., Emerson SS; Department of Biostatistics, University of Washington, Seattle, WA, USA., Kahn SE; Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA; University of Washington, Seattle, WA, USA., Kitzman DW; Wake Forest University School of Medicine, Winston-Salem, NC, USA., Lingvay I; University of Texas Southwestern Medical Center, Dallas, TX, USA., Mahaffey KW; Stanford Center for Clinical Research, Stanford School of Medicine, Palo Alto, CA, USA., Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Plutzky J; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Rasmussen S; Novo Nordisk, Søborg, Denmark., Rönnbäck C; Novo Nordisk, Søborg, Denmark., Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Verma S; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON, Canada., Weeke PE; Novo Nordisk, Søborg, Denmark., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Corporate Authors: SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM Trial Committees and Investigators
Source: Lancet (London, England) [Lancet] 2024 Sep 07; Vol. 404 (10456), pp. 949-961. Date of Electronic Publication: 2024 Aug 30.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-547X
DOI:10.1016/S0140-6736(24)01643-X